Early results show that CAR T cells successfully engrafted in three patients, leading to remission across different autoimmune diseases. While the findings are promising, with over 40 clinical trials underway, safety remains a crucial concern. The initial data suggests that CAR T cells for autoimmune conditions may present fewer risks compared to their use in cancer treatments.
